Sponsor Pipeline

Anders Fink-Jensen, MD, DMSci Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
3
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-02 NCT04718792
Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study		 overall status: Active, Not Recruiting → Unknown
Active Trials by Phase
Phase 4
1
Phase 2
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT04892199 Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic… Metabolic Disturbance Active, Not Recruiting
Phase 2
NCT06939088 Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and… Alcohol Use Disorder Recruiting
NCT07523633 Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder Cannabis Use Disorder Recruiting
Not specified
NCT06866379 Involvement of the Septal Nuclei of the Human Brain in Alcohol Use Disorder Alcohol Use Disorder Recruiting
Disease Areas
Schizophrenia (2) Type 2 Diabetes (1) Diabetes (1)
Get alerts when Anders Fink-Jensen, MD, DMSci's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free